C 13 H 16 N 2 O4, monoclinic, P21/c (no. 14), a = 13.312(2) Å, b = 8.8222(13) Å, c = 12.4784(18) Å, β = 115.350(2)°, V = 1324.4(3) Å 3 , Z = 4, Rgt(F) = 0.0372, wR ref (F 2 ) = 0.0739, T = 293 K.
Source of material
All of starting materials are commercially available. The title compound was synthesized via bis(4hydroxyphenyl)methanone with excess hydrazine hydrate in ethanol solution containing a few drops glacial acetic acid 
Experimental details
Hydrogen atoms were placed in calculated positions and were included in the refinement using the riding model approximation, with U iso = 1.2Ueq(C). Nitrogen-bound and oxygenbound H atoms were refined subject to distance restraints with U iso = 1.2Ueq(N) and U iso = 1.5Ueq(O), respectively.
Comment
Owing to their multiple coordination chemistry properties and biological activities, pharmaceutical properties, Schiff bases have received considerable attention [3] [4] [5] [6] [7] [8] [9] [10] . In order to search for new Schiff bases with higher biological activities, the title compound was synthesized and its crystal structure is reported here. The asymmetric unit of the title compound consists of one formula unit (cf. the figure). In the crystal structure of title compound, the short distance d(N1-C1) = 1.2869(18) Å has a value of a typical C=N double bond. The C=N bond length is similar to the previous reported structure, (bis(4-methoxyphenyl)methylene)hydrazine of 1.2912(16) Å [11] . The two phenyl rings are almost vertical to each other with the dihedral angle of 89.19°. While in (bis(4methoxyphenyl)methylene)hydrazine, this dihedral angle is 80.57°. The molecules are packed in the crystal structure via abundant classical O-H· · · O, O-H· · · N and N-H· · · O hydrogen bonds.
